RECRUITING

Assessing Ketorolac (Toradol) at Oocyte Retrieval

Talk to us

Conditions

InfertilityInfertility, FemaleOocyte RetrievalPostoperative PainEmbryo TransferIn Vitro FertilizationIVFPostoperative Pain ControlNSAIDKetorolacNon-Narcotic Analgesia

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To determine if a nonsteroidal anti-inflammatory drug (NSAID), Ketorolac (Toradol), can improve pain control and decrease narcotic use after undergoing egg retrieval.

Official Title

A Randomized Blinded Placebo Controlled Trial Assessing Ketorolac (Toradol) at Oocyte Retrieval

Quick Facts

Study Start:2022-08-10
Study Completion:2025-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06026553

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Signed informed consent
  2. 2. Females over 18 years of age who are scheduled to undergo oocyte retrieval
  3. 3. Patients must be able to read and understand written English or have an appropriate certified medical translator available.
  4. 4. Standard eligibility criteria to undergo IVF and embryo transfer at Shady Grove
  1. 1. Known allergy to ketorolac
  2. 2. Those with known medical conditions precluding them from ketorolac use (active peptic ulcer disease, recent or history of hemorrhage or perforation, known renal or hepatic insufficiency, suspected or confirmed cerebrovascular bleeding, hemorrhagic diathesis, bleeding disorders, recent myocardial infarction, or stroke.)
  3. 3. BMI ≥ 40 kg/m2
  4. 4. History of substance abuse
  5. 5. Chronic opioid use
  6. 6. Transabdominal oocyte retrieval

Contacts and Locations

Study Contact

Tasha Newsome
CONTACT
(301)545-1289
tasha.newsome@sgfertility.com

Principal Investigator

Kathleen Devine, MD
PRINCIPAL_INVESTIGATOR
Shady Grove Fertility Reproductive Science Center

Study Locations (Sites)

Shady Grove Fertility Reproductive Science Center
Rockville, Maryland, 20850
United States
Shady Grove Fertility Reproductive Science Center
Fairfax, Virginia, 22031
United States

Collaborators and Investigators

Sponsor: Shady Grove Fertility Reproductive Science Center

  • Kathleen Devine, MD, PRINCIPAL_INVESTIGATOR, Shady Grove Fertility Reproductive Science Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-08-10
Study Completion Date2025-01

Study Record Updates

Study Start Date2022-08-10
Study Completion Date2025-01

Terms related to this study

Keywords Provided by Researchers

  • Infertility, Female
  • In Vitro Fertilization
  • IVF
  • Oocyte Retrieval
  • Postoperative Pain Control
  • NSAID
  • Ketorolac
  • Non-Narcotic Analgesia

Additional Relevant MeSH Terms

  • Infertility
  • Infertility, Female
  • Oocyte Retrieval
  • Postoperative Pain
  • Embryo Transfer